Collecting and analyzing data is a contentious question. High-profile data mavens offered some possible answers yesterday at the JP Morgan Healthcare Conference.
Day 2 at JP Morgan ’18: Pharma’s need for more diversity and data sharing grab the spotlight
How drugmakers should prepare for and respond to the forces poised to reshape the industry was a popular topic on day one of the 36th annual JP Morgan Healthcare Conference.
Five things for pharma marketers to know: Wednesday, January 3, 2018
Utah Senator who backed Orphan Drug Act will not seek reelection; medicines more expensive in 2018; Spark’s genetic therapy for rare blindness costs $850,000
Five things for pharma marketers to know: Tuesday, January 2, 2018